Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: New Pacer--UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK
1
Apr 30, 2009 10:13PM

It is my understanding that the current licensing strategy is to focus on selling system licenses to the end user market and a royalty free license to chip manufacturers. I was under the impression that it is still legal to do this and that is what they are doing - focusing on selling system licenses.

<If TPL had licensed or sued the Manufacture of the 212 chip, Sirus would probably not be subject to any infringement. >

Are saying that current licensing strategy is not legal, or you are saying that if Alliacense chose a different strategy than the one employed?

Opty

11
May 01, 2009 08:44AM
5
May 02, 2009 08:20AM
Share
New Message
Please login to post a reply